Log in to save to my catalogue

Single and Combined IL28B , ITPA and SLC28A3 Host Genetic Markers Modulating Response to Anti-hepati...

Single and Combined IL28B , ITPA and SLC28A3 Host Genetic Markers Modulating Response to Anti-hepati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1356930281

Single and Combined IL28B , ITPA and SLC28A3 Host Genetic Markers Modulating Response to Anti-hepatitis C Therapy

About this item

Full title

Single and Combined IL28B , ITPA and SLC28A3 Host Genetic Markers Modulating Response to Anti-hepatitis C Therapy

Publisher

England: Future Medicine Ltd

Journal title

Pharmacogenomics, 2011-12, Vol.12 (12), p.1729-1740

Language

English

Formats

Publication information

Publisher

England: Future Medicine Ltd

More information

Scope and Contents

Contents

Advances in hepatitis C pharmacogenomics identified modulations of a sustained virologic response (SVR) by frequent IL28B gene variants and of ribavirin-induced hemolysis by frequent ITPA gene variants. These associations have been widely reproduced in various ethnicities, clinical settings and hepatitis C viral genotypes. The IL28B minor alleles r...

Alternative Titles

Full title

Single and Combined IL28B , ITPA and SLC28A3 Host Genetic Markers Modulating Response to Anti-hepatitis C Therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1356930281

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1356930281

Other Identifiers

ISSN

1462-2416

E-ISSN

1744-8042

DOI

10.2217/pgs.11.99

How to access this item